Simvastatin is effective in killing the radioresistant breast carcinoma cells

1EU Science Hub. 2020 Cancer incidence and mortality in EU-27 countries. [Internet]. [cited 2021 Jan 22]. Available at: https://ec.europa.eu/jrc/en/news/2020-cancer-incidence-and-mortality-eu-27-countriesEU Science Hub 2020 Cancer incidence and mortality in EU-27 countries. [Internet] [cited 2021 Jan 22]. Available at https://ec.europa.eu/jrc/en/news/2020-cancer-incidence-and-mortality-eu-27-countriesSearch in Google Scholar

2Thomas MA, Ochoa LL, Zygmunt TM, Matesa M, Altman MB, Garcia-Ramirez JL, et al. Accelerated partial breast irradiation: a safe, effective, and convenient early breast cancer treatment option. Mo Med 2015; 112: 379-84. PMID: 26606820Thomas MA Ochoa LL Zygmunt TM Matesa M Altman MB Garcia-Ramirez JL et al Accelerated partial breast irradiation: a safe, effective, and convenient early breast cancer treatment option Mo Med 2015 112 379 84 PMID: 26606820Search in Google Scholar

3Merino T, Tran WT, Czarnota GJ. Re-irradiation for locally recurrent refractory breast cancer. Oncotarget 2015; 6: 35051-62. doi: 10.18632/onco-target.6036Merino T Tran WT Czarnota GJ Re-irradiation for locally recurrent refractory breast cancer Oncotarget 2015 6 35051 62 10.18632/onco-target.6036Open DOISearch in Google Scholar

4Siglin J, Champ CE, Vakhnenko Y, Anne PR, Simone NL. Radiation therapy for locally recurrent breast cancer. Int J Breast Cancer 2012; 2012: 571946. doi: 10.1155/2012/571946Siglin J Champ CE Vakhnenko Y Anne PR Simone NL Radiation therapy for locally recurrent breast cancer Int J Breast Cancer 2012 2012 571946 10.1155/2012/571946347145223091733Open DOISearch in Google Scholar

5Fredriksson I, Liljegren G, Arnesson L-G, Emdin SO, Palm-Sjövall M, Fornander T, et al. Local recurrence in the breast after conservative surgery − a study of prognosis and prognostic factors in 391 women. Eur J Cancer 2002; 38: 1860-70. doi: 10.1016/s0959-8049(02)00219-8Fredriksson I Liljegren G Arnesson L-G Emdin SO Palm-Sjövall M Fornander T et al Local recurrence in the breast after conservative surgery − a study of prognosis and prognostic factors in 391 women Eur J Cancer 2002 38 1860 70 10.1016/s0959-8049(02)00219-812204668Open DOISearch in Google Scholar

6Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 2005; 63: 845-51. doi: 10.1016/j.ijrobp.2005.02.035Alpert TE Kuerer HM Arthur DW Lannin DR Haffty BG Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 2005 63 845 51 10.1016/j.ijrobp.2005.02.03516199315Open DOISearch in Google Scholar

7Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 2002; 95: 2059-67. doi: 10.1002/cncr.10952Huang E Buchholz TA Meric F Krishnamurthy S Mirza NQ Ames FC et al Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences Cancer 2002 95 2059 67 10.1002/cncr.1095212412158Open DOISearch in Google Scholar

8Bedwinek J. Natural history and management of isolated local-regional recurrence following mastectomy. Semin Radiat Oncol 1994; 4: 260-9. doi: 10.1053/SRAO00400260Bedwinek J Natural history and management of isolated local-regional recurrence following mastectomy Semin Radiat Oncol 1994 4 260 9 10.1053/SRAO0040026010717115Open DOISearch in Google Scholar

9Belkacemi Y, Hanna NE, Besnard C, Majdoul S, Gligorov J. Local and regional breast cancer recurrences: salvage therapy options in the new era of molecular subtypes. Front Oncol 2018; 8: 112. doi: 10.3389/fonc.2018.00112Belkacemi Y Hanna NE Besnard C Majdoul S Gligorov J Local and regional breast cancer recurrences: salvage therapy options in the new era of molecular subtypes Front Oncol 2018 8 112 10.3389/fonc.2018.00112591332729719816Open DOISearch in Google Scholar

10Matusewicz L, Czogalla A, Sikorski AF. Attempts to use statins in cancer therapy: an update. Tumor Biol 2020; 42: 1010428320941760. doi: 10.1177/1010428320941760Matusewicz L Czogalla A Sikorski AF Attempts to use statins in cancer therapy: an update Tumor Biol 2020 42 1010428320941760 10.1177/101042832094176032662332Open DOISearch in Google Scholar

11Skvortsova I, Skvortsov S, Popper BA, Haidenberger A, Saurer M, Gunkel AR, et al. Rituximab enhances radiation-triggered apoptosis in Non-Hodgkin’s lymphoma cells via caspase-dependent and-independent mechanisms. J Radiat Res 2006; 47: 183-96. doi: 10.1269/jrr.47.183Skvortsova I Skvortsov S Popper BA Haidenberger A Saurer M Gunkel AR et al Rituximab enhances radiation-triggered apoptosis in Non-Hodgkin’s lymphoma cells via caspase-dependent and-independent mechanisms J Radiat Res 2006 47 183 96 10.1269/jrr.47.18316819145Open DOISearch in Google Scholar

12Skvortsova I, Skvortsov S, Haidenberger A, Devries A, Nevinny-Stickel M, Saurer M, et al. Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro. J Chemother 2004; 16: 372-80. doi: 10.1179/joc.2004.16.4.372Skvortsova I Skvortsov S Haidenberger A Devries A Nevinny-Stickel M Saurer M et al Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro J Chemother 2004 16 372 80 10.1179/joc.2004.16.4.37215332713Open DOISearch in Google Scholar

13Skvortsov S, Sarg B, Lindner H, Lukas P, Hilbe W, Zwierzina H, et al. Cetuximab inhibits thymidylate synthase in colorectal cells expressing epidermal growth factor receptor. Proteomics Clin Appl 2008; 2: 908-14. doi: 10.1002/prca.200780034Skvortsov S Sarg B Lindner H Lukas P Hilbe W Zwierzina H et al Cetuximab inhibits thymidylate synthase in colorectal cells expressing epidermal growth factor receptor Proteomics Clin Appl 2008 2 908 14 10.1002/prca.20078003421136888Open DOISearch in Google Scholar

14Choi J, Yoon YN, Kim N, Park CS, Seol H, Park I-C, et al. Predicting radiation resistance in breast cancer with expression status of phosphorylated S6K1. Sci Rep 2020; 10: 641. doi: 10.1038/s41598-020-57496-8Choi J Yoon YN Kim N Park CS Seol H Park I-C et al Predicting radiation resistance in breast cancer with expression status of phosphorylated S6K1 Sci Rep 2020 10 641 10.1038/s41598-020-57496-8697127531959810Open DOISearch in Google Scholar

15Garcia-Estevez L, Moreno-Bueno G. Updating the role of obesity and cholesterol in breast cancer. Breast Cancer Res 2019; 21: 35. doi: 10.1186/s13058-019-1124-1Garcia-Estevez L Moreno-Bueno G Updating the role of obesity and cholesterol in breast cancer Breast Cancer Res 2019 21 35 10.1186/s13058-019-1124-1639748530823902Open DOISearch in Google Scholar

16Hirata E, Sahai E. Tumor microenvironment and differential responses to therapy. Cold Spring Harb Perspect Med 2017; 7: a026781. doi: 10.1101/cshperspect.a026781Hirata E Sahai E Tumor microenvironment and differential responses to therapy Cold Spring Harb Perspect Med 2017 7 a026781 10.1101/cshperspect.a026781549505128213438Open DOISearch in Google Scholar

17Bjarnadottir O, Feldt M, Inasu M, Bendahl PO, Elebro K, Kimbung S, et al. Statin use, HMGCR expression, and breast cancer survival - The Malmo Diet and Cancer Study. Sci Rep 2020; 10: 558. doi: 10.1038/s41598-019-57323-9Bjarnadottir O Feldt M Inasu M Bendahl PO Elebro K Kimbung S et al Statin use, HMGCR expression, and breast cancer survival - The Malmo Diet and Cancer Study Sci Rep 2020 10 558 10.1038/s41598-019-57323-9696910831953433Open DOISearch in Google Scholar

18Arnold CR, Mangesius J, Skvortsova II, Ganswindt U. The role of cancer stem cells in radiation resistance. Front Oncol 2020; 10: 164. doi: 10.3389/fonc.2020.00164Arnold CR Mangesius J Skvortsova II Ganswindt U The role of cancer stem cells in radiation resistance Front Oncol 2020 10 164 10.3389/fonc.2020.00164704440932154167Open DOISearch in Google Scholar

19Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova I-I. Therapy resistance mediated by cancer stem cells. Semin Cancer Biol 2018; 53: 156-67. doi: 10.1016/j.semcancer.2018.11.006Steinbichler TB Dudás J Skvortsov S Ganswindt U Riechelmann H Skvortsova I-I Therapy resistance mediated by cancer stem cells Semin Cancer Biol 2018 53 156 67 10.1016/j.semcancer.2018.11.00630471331Open DOISearch in Google Scholar

20Steinbichler TB, Savic D, Dudás J, Kvitsaridze I, Skvortsov S, Riechelmann H, et al. Cancer stem cells and their unique role in metastatic spread. Semin Cancer Biol 2020; 60: 148-56. doi: 10.1016/j.semcancer.2019.09.007Steinbichler TB Savic D Dudás J Kvitsaridze I Skvortsov S Riechelmann H et al Cancer stem cells and their unique role in metastatic spread Semin Cancer Biol 2020 60 148 56 10.1016/j.semcancer.2019.09.00731521746Open DOISearch in Google Scholar

21Wu QJ, Tu C, Li YY, Zhu J, Qian KQ, Li WJ, et al. Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget 2015; 6: 42988-3004. doi: 10.18632/oncotarget.5557Wu QJ Tu C Li YY Zhu J Qian KQ Li WJ et al Statin use and breast cancer survival and risk: a systematic review and meta-analysis Oncotarget 2015 6 42988 3004 10.18632/oncotarget.5557476748626472026Open DOISearch in Google Scholar

22Efimova E V, Ricco N, Labay E, Mauceri HJ, Flor AC, Ramamurthy A, et al. HMG-CoA reductase inhibition delays DNA repair and promotes senescence after tumor irradiation. Mol Cancer Ther 2018; 17: 407-18. doi: 10.1158/1535-7163.MCT-17-0288Efimova E V Ricco N Labay E Mauceri HJ Flor AC Ramamurthy A et al HMG-CoA reductase inhibition delays DNA repair and promotes senescence after tumor irradiation Mol Cancer Ther 2018 17 407 18 10.1158/1535-7163.MCT-17-0288580562329030460Open DOISearch in Google Scholar

23Longo J, van Leeuwen JE, Elbaz M, Branchard E, Penn LZ. Statins as anticancer agents in the era of precision medicine. Clin Cancer Res 2020; 26: 5791-800. doi: 10.1158/1078-0432.CCR-20-1967Longo J van Leeuwen JE Elbaz M Branchard E Penn LZ Statins as anticancer agents in the era of precision medicine Clin Cancer Res 2020 26 5791 800 10.1158/1078-0432.CCR-20-196732887721Open DOISearch in Google Scholar

24Kaplan-Meier Plotter. Breast cancer. [Internet]. [cited 2021 Jan 22]. Available at: https://kmplot.com/analysis/Kaplan-Meier Plotter. Breast cancer. [Internet] [cited 2021 Jan 22]. Available at https://kmplot.com/analysis/Search in Google Scholar

25Ricco N, Flor A, Wolfgeher D, Efimova EV, Ramamurthy A, Appelbe OK, et al. Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer. Mol Oncol 2019; 13: 1927-43. doi: 10.1002/1878-0261.12535Ricco N Flor A Wolfgeher D Efimova EV Ramamurthy A Appelbe OK et al Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer Mol Oncol 2019 13 1927 43 10.1002/1878-0261.12535671775931225926Open DOISearch in Google Scholar

26Wolfe AR, Debeb BG, Lacerda L, Larson R, Bambhroliya A, Huang X, et al. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a. Breast Cancer Res Treat 2015; 154: 495-508. doi: 10.1007/s10549-015-3645-3Wolfe AR Debeb BG Lacerda L Larson R Bambhroliya A Huang X et al Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a Breast Cancer Res Treat 2015 154 495 508 10.1007/s10549-015-3645-3590198226590814Open DOISearch in Google Scholar

27Wolfe AR, Woodward WA. Breast cancer stem cell correlates as predicative factors for radiation therapy. Semin Radiat Oncol 2015; 25: 251-9. doi: 10.1016/j.semradonc.2015.05.009Wolfe AR Woodward WA Breast cancer stem cell correlates as predicative factors for radiation therapy Semin Radiat Oncol 2015 25 251 9 10.1016/j.semradonc.2015.05.00926384273Open DOISearch in Google Scholar

28Van Wyhe RD, Rahal OM, Woodward WA. Effect of statins on breast cancer recurrence and mortality: a review. Breast Cancer 2017; 9: 559-65. doi: 10.2147/BCTT.S148080Van Wyhe RD Rahal OM Woodward WA Effect of statins on breast cancer recurrence and mortality: a review Breast Cancer 2017 9 559 65 10.2147/BCTT.S148080571632029238220Open DOISearch in Google Scholar

29Rahal OM, Woodward WA. Cholesterol and radiosensitivity. Curr Breast Cancer Rep 2016; 8: 32-9. doi: 10.1007/s12609-016-0202-yRahal OM Woodward WA Cholesterol and radiosensitivity Curr Breast Cancer Rep 2016 8 32 9 10.1007/s12609-016-0202-yOpen DOISearch in Google Scholar

30Jin Y, Xu K, Chen Q, Wang B, Pan J, Huang S, et al. Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway. Exp Cell Res 2018; 362: 362-9. doi: 10.1016/j.yexcr.2017.11.037Jin Y Xu K Chen Q Wang B Pan J Huang S et al Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway Exp Cell Res 2018 362 362 9 10.1016/j.yexcr.2017.11.03729208461Open DOISearch in Google Scholar

31Xie F, Liu J, Li C, Zhao Y. Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells. Oncol Lett 2016; 11: 3377-83. doi: 10.3892/ol.2016.4404Xie F Liu J Li C Zhao Y Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells Oncol Lett 2016 11 3377 83 10.3892/ol.2016.4404484097327123120Open DOISearch in Google Scholar

32Kato S, Liberona MF, Cerda-Infante J, Sánchez M, Henríquez J, Bizama C, et al. Simvastatin interferes with cancer “stem-cell” plasticity reducing metastasis in ovarian cancer. Endocr Relat Cancer 2018; 25: 821-36. doi: 10.1530/ERC-18-0132Kato S Liberona MF Cerda-Infante J Sánchez M Henríquez J Bizama C et al Simvastatin interferes with cancer “stem-cell” plasticity reducing metastasis in ovarian cancer Endocr Relat Cancer 2018 25 821 36 10.1530/ERC-18-013229848667Open DOISearch in Google Scholar

33Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 2011; 103: 1461-8. doi: 10.1093/jnci/djr291Ahern TP Pedersen L Tarp M Cronin-Fenton DP Garne JP Silliman RA et al Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study J Natl Cancer Inst 2011 103 1461 8 10.1093/jnci/djr291318678021813413Open DOISearch in Google Scholar

34Manthravadi S, Shrestha A, Madhusudhana S. Impact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysis. Int J cancer 2016; 139: 1281-8. doi: 10.1002/ijc.30185Manthravadi S Shrestha A Madhusudhana S Impact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysis Int J cancer 2016 139 1281 8 10.1002/ijc.3018527176735Open DOISearch in Google Scholar

35Bhutia SK, Mukhopadhyay S, Sinha N, Das DN, Panda PK, Patra SK, et al. Autophagy: cancer’s friend or foe? Adv Cancer Res 2013; 118: 61-95. doi: 10.1016/B978-0-12-407173-5.00003-0Bhutia SK Mukhopadhyay S Sinha N Das DN Panda PK Patra SK et al Autophagy: cancer’s friend or foe? Adv Cancer Res 2013 118 61 95 10.1016/B978-0-12-407173-5.00003-0434937423768510Open DOISearch in Google Scholar